AAAAAA

   
Results: 1-9 |
Results: 9
THE CLONAL COMPOSITION OF A PEPTIDE-SPECIFIC OLIGOCLONAL CTL REPERTOIRE SELECTED IN RESPONSE TO PERSISTENT EBV INFECTION IS STABLE OVER TIME
Authors: LEVITSKY V DECAMPOSLIMA PO FRISAN T MASUCCI MG
Citation: V. Levitsky et al., THE CLONAL COMPOSITION OF A PEPTIDE-SPECIFIC OLIGOCLONAL CTL REPERTOIRE SELECTED IN RESPONSE TO PERSISTENT EBV INFECTION IS STABLE OVER TIME, The Journal of immunology (1950), 161(2), 1998, pp. 594-601
PHENOTYPE-DEPENDENT DIFFERENCES IN PROTEASOME SUBUNIT COMPOSITION ANDCLEAVAGE SPECIFICITY IN B-CELL LINES
Authors: FRISAN T LEVITSKY V POLACK A MASUCCI MG
Citation: T. Frisan et al., PHENOTYPE-DEPENDENT DIFFERENCES IN PROTEASOME SUBUNIT COMPOSITION ANDCLEAVAGE SPECIFICITY IN B-CELL LINES, The Journal of immunology, 160(7), 1998, pp. 3281-3289
STRATEGIES OF IMMUNOESCAPE IN EPSTEIN-BARR-VIRUS PERSISTENCE AND PATHOGENESIS
Authors: DECAMPOSLIMA PO LEVITSKAYA J FRISAN T MASUCCI MG
Citation: Po. Decamposlima et al., STRATEGIES OF IMMUNOESCAPE IN EPSTEIN-BARR-VIRUS PERSISTENCE AND PATHOGENESIS, Seminars in virology, 7(1), 1996, pp. 75-82
DEFECTIVE PRESENTATION OF MHC CLASS I-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN BURKITTS-LYMPHOMA CELLS
Authors: FRISAN T ZHANG QJ LEVITSKAYA J CORAM M KURILLA MG MASUCCI MG
Citation: T. Frisan et al., DEFECTIVE PRESENTATION OF MHC CLASS I-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN BURKITTS-LYMPHOMA CELLS, International journal of cancer, 68(2), 1996, pp. 251-258
IDENTIFICATION AND CHARACTERIZATION OF AN EPSTEIN-BARR VIRUS-SPECIFICT-CELL RESPONSE IN THE PATHOLOGICAL TISSUE OF A PATIENT WITH HODGKINS-DISEASE
Authors: DOLCETTI R FRISAN T SJOBERG J DECAMPOSLIMA PO PISA P DERE V GLOGHINI A RIZZO S MASUCCI MG BOIOCCHI M
Citation: R. Dolcetti et al., IDENTIFICATION AND CHARACTERIZATION OF AN EPSTEIN-BARR VIRUS-SPECIFICT-CELL RESPONSE IN THE PATHOLOGICAL TISSUE OF A PATIENT WITH HODGKINS-DISEASE, Cancer research, 55(16), 1995, pp. 3675-3681
LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE
Authors: FRISAN T SJOBERG J DOLCETTI R BOIOCCHI M DERE V CARBONE A BRAUTBAR C BATTAT S BIBERFELD P ECKMAN M OST O CHRISTENSSON B SUNDSTROM C BJORKHOLM M PISA P MASUCCI MG
Citation: T. Frisan et al., LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE, Blood, 86(4), 1995, pp. 1493-1501
DIFFERENT IMMUNOGENICITY OF 2 HLAA11 RESTRICTED CTL EPITOPES IN THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-4
Authors: LEVITSKY V ZHANG QJ FRISAN T DECAMPOSLIMA PO MASUCCI MG
Citation: V. Levitsky et al., DIFFERENT IMMUNOGENICITY OF 2 HLAA11 RESTRICTED CTL EPITOPES IN THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-4, Journal of cellular biochemistry, 1994, pp. 232-232
IN-VIVO PHENOTYPIC CHARACTERIZATIONS OF AKR T-CELL LYMPHOMAS WITH DIFFERENT LEUKEMIC POTENTIAL - POSSIBLE ROLE OF ALPHA-4-BETA-7 INTEGRIN IN THE PROGRESSION TOWARDS THE LEUKEMIC PHENOTYPE
Authors: DOLCETTI R FRISAN T PALMIERI G RIZZO S MAESTRO R SANTONI A BOIOCCHI M
Citation: R. Dolcetti et al., IN-VIVO PHENOTYPIC CHARACTERIZATIONS OF AKR T-CELL LYMPHOMAS WITH DIFFERENT LEUKEMIC POTENTIAL - POSSIBLE ROLE OF ALPHA-4-BETA-7 INTEGRIN IN THE PROGRESSION TOWARDS THE LEUKEMIC PHENOTYPE, International journal of cancer, 56(4), 1994, pp. 560-567
TYPE-2 EPSTEIN-BARR-VIRUS GENOME AND LATENT MEMBRANE PROTEIN-1 EXPRESSION IN A T-CELL-RICH LYMPHOMA OF PROBABLE B-CELL LINEAGE
Authors: DOLCETTI R CARBONE A ZAGONEL V DERE V GLOGHINI A FRISAN T BOIOCCHI M
Citation: R. Dolcetti et al., TYPE-2 EPSTEIN-BARR-VIRUS GENOME AND LATENT MEMBRANE PROTEIN-1 EXPRESSION IN A T-CELL-RICH LYMPHOMA OF PROBABLE B-CELL LINEAGE, American journal of clinical pathology, 100(5), 1993, pp. 541-549
Risultati: 1-9 |